首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   30162篇
  免费   2160篇
  国内免费   185篇
耳鼻咽喉   56篇
儿科学   338篇
妇产科学   403篇
基础医学   3930篇
口腔科学   520篇
临床医学   2134篇
内科学   8093篇
皮肤病学   636篇
神经病学   718篇
特种医学   192篇
外国民族医学   2篇
外科学   1310篇
综合类   2538篇
现状与发展   2篇
一般理论   18篇
预防医学   8444篇
眼科学   177篇
药学   2044篇
  2篇
中国医学   514篇
肿瘤学   436篇
  2024年   12篇
  2023年   366篇
  2022年   336篇
  2021年   727篇
  2020年   940篇
  2019年   1023篇
  2018年   1091篇
  2017年   1123篇
  2016年   1224篇
  2015年   1097篇
  2014年   1856篇
  2013年   3576篇
  2012年   1768篇
  2011年   2063篇
  2010年   1757篇
  2009年   1688篇
  2008年   1560篇
  2007年   1608篇
  2006年   1463篇
  2005年   957篇
  2004年   857篇
  2003年   802篇
  2002年   643篇
  2001年   588篇
  2000年   479篇
  1999年   395篇
  1998年   294篇
  1997年   324篇
  1996年   224篇
  1995年   215篇
  1994年   217篇
  1993年   230篇
  1992年   210篇
  1991年   203篇
  1990年   143篇
  1989年   159篇
  1988年   101篇
  1987年   74篇
  1986年   49篇
  1985年   36篇
  1984年   25篇
  1983年   3篇
  1977年   1篇
排序方式: 共有10000条查询结果,搜索用时 281 毫秒
1.
BackgroundPrior to dolutegravir availability, ritonavir-boosted lopinavir (LPV/r) was an alternative recommendation when first-line drugs could not be used. A high concentration of protease inhibitors was observed in the Thai people living with HIV (PLWH). Thus, dose reduction of LPV/r may be possible. However, the pharmacokinetics and dose optimization of LPV/r have never been investigated. This study aimed to develop a population pharmacokinetic model of LPV/r and provide dosage optimization in Thai PLWH.MethodsLPV and RTV trough concentrations from Thai PLWH were combined with intensive data. The data were analyzed by the nonlinear mixed-effects modeling approach. The influence of RTV concentration on LPV oral clearance (CL/F) was investigated.ResultsRifampicin (RIF) use increased LPV and RTV CL/F by 2.16-fold and 1.99-fold, respectively. The reduced dose of 300/75 and 200/150 mg twice daily provided a comparable percentage of patients achieving LPV target trough concentration to the standard dose for PI-naïve patients. For HIV/TB co-infected patients receiving RIF who could not tolerate the recommended dose, the reduced dose of 600/150 mg twice daily was recommended.ConclusionThe population pharmacokinetic model was developed by integrating the interaction between LPV and RTV. The reduced LPV/r dosage offers sufficient LPV exposure for Thai PLWH.  相似文献   
2.
We are reporting (a) updated incidence of cervical intraepithelial neoplasia (CIN) among women who did not have colposcopic or histopathological disease at baseline and (b) disease outcomes among women treated for CIN and their follow-up HPV status; in a cohort of women living with HIV (WHIV). The median overall follow-up was 3.5 years (IQR 2.8-4.3). The incidence of any CIN and that of CIN 2 or worse disease was 16.7 and 7.0 per 1000 person-years of observation (PYO), respectively. Compared with women who were HPV negative at baseline, women who cleared HPV infection had 23.95 times increased risk of incident CIN 2 or worse lesions (95% CI 2.40-661.07). Women with persistent HPV infection had 138.18 times increased risk of CIN 2 or worse lesions (95% CI 20.30-3300.22). Complete disease regression was observed in 65.6% of the HPV positive women with high-grade CIN and were treated with thermal ablation but HPV persistence was seen in 44.8% of those with high-grade disease. Among those who did not have any disease at baseline and were also HPV negative, about 87% (95% CI 83.79-89.48) women remained HPV negative during consecutive HPV test/s with the median interval of 3.5 years. Long-term surveillance of WHIV treated for any CIN is necessary for the prevention of cervical cancer among them. Our study provides an early indication that the currently recommended screening interval of 3 to 5 years among WHIV may be extended to at least 5 years among HPV negative women. Increasing the screening interval can be cost saving and improve scalability among WHIV to support WHO's cervical cancer elimination initiative.  相似文献   
3.
背景 结核性脑膜炎(TM)是临床常见的中枢性感染的一种,其起病较慢,症状不典型,病原学诊断困难,误诊率高。目前有效的TM诊断工具较少。利用常见的临床症状、检查指标等建立诊断评分系体可提高诊断准确率,减少误诊。 目的 建立TM临床诊断评分体系(TMCDS),并对其应用价值进行初步评价。 方法 选取2011年11月至2021年9月在柳州市人民医院感染病科住院并诊断为脑膜炎的患者187例为研究对象,采用SPSS 21.0统计软件将患者随机分成建模组(147例)和验模组(40例)。根据是否为TM将建模组分为非TM亚组(76例)和TM亚组(71例)。收集患者的一般资料,主要包括性别、年龄、临床症状(发热、头痛、意识障碍、颈抵抗),实验室及影像学检查结果,包括人类免疫缺陷病毒(HIV)感染情况、CD4+ T淋巴细胞计数、C反应蛋白、颅内压、脑脊液常规生化检查(糖、氯、蛋白、细胞数)。建模组采用多因素Logistic回归分析探讨TM的影响因素;根据每个因素的β值所占比重设立相应分值,建立TMCDS;采用受试者工作特征曲线(ROC曲线)分析TMCDS诊断TM的价值。 结果 两亚组头痛、HIV感染、CD4+ T淋巴细胞计数<200/μl、C反应蛋白升高、颅内压>200 mm H2O(1 mm H2O=0.009 8 kPa)、脑脊液糖降低、脑脊液氯降低、脑脊液蛋白升高、脑脊液单核细胞升高情况比较,差异有统计学意义(P<0.05)。多因素Logistic回归分析结果显示,头痛、CD4+ T淋巴细胞<200/μl、C反应蛋白升高、脑脊液糖降低、脑脊液蛋白升高均是TM的影响因素(P<0.05)。将以上5个影响因素同时结合临床经验纳入脑脊液氯、脑脊液细胞数再次进行多因素Logistic回归分析,结果显示,头痛、CD4+ T淋巴细胞<200/μl、C反应蛋白升高、脑脊液糖降低、脑脊液蛋白升高均是TM的影响因素(P<0.05)。根据上述7个因素β值建立评分系统,将脑脊液氯降低β值设定为1分,其他因素β值与其的倍数即为该因素所对应的分值,因2个影响因素评分为负值,为方便临床,每个因素对应分值增加2.5分,最终建立TMCDS。TMCDS诊断建模组TM的ROC曲线下面积(AUC)为0.807〔95%CI(0.735,0.879),标准误=0.037,P<0.001〕,最佳诊断界值为21.50分。TMCDS诊断验模组TM的AUC为0.766〔95%CI(0.610,0.921),标准误=0.079,P=0.004〕,灵敏度为0.789,特异度为0.667。 结论 通过7个变量建立的TMCDS简单易行,对于早期TM具有较高的临床诊断价值。  相似文献   
4.
目的 分析南京市某国际高中学生艾滋病知识知晓率及其影响因素,为制定高中生艾滋病健康教育策略提供依据。方法 对南京市某国际高中所有学生开展纸质问卷调查,统计分析艾滋病知识知晓率及其影响因素。 共纳入171名高中生为调查对象,艾滋病和梅毒的知识知晓率分别为56.1%和46.8%;有过性行为的占14.6%,其艾滋病知识知晓率最高为32.0%,(χ2=10.799,P=0.005);有吸毒史的学生占9.3%,其艾滋病知识知晓率最高为31.2%,(χ2=21.062,P<0.001);梅毒知识知晓者与不知晓者的艾滋病知识知晓率差异具有统计学意义(χ2=21.716,P<0.001)。 该国际高中学生性病和艾滋病知识知晓率较低,对高中生开展毒品危害教育和性病艾滋病防治应作为健康教育工作重点。  相似文献   
5.
目的探讨艾滋病合并肺结核患者行胸部CT检查的影像学特征及其在疾病诊断上的价值。方法选取本院在2018年3月至2019年4月诊治的40例艾滋病合并肺结核患者作为观察组,同时选择同期入院诊治40例单纯肺结核患者作为对照组。给予两组胸部CT检查,分析影像学特征,并探讨其诊断价值。结果与对照组比较,观察组淋巴结或胸膜受累所占比较明显更高,差异有统计学意义(P<0.05);与综合检查诊断结果比较,胸部CT检查继发性肺结核、血行播散型肺结核诊断准确率分别为96.55%、91.67%,漏诊2例(5.00%);艾滋病伴肺结核患者接受胸部CT检查时,影像学特征主要表现为双肺肺叶、肺段可见明显渗出性病变,肺内纤维索条影显示明显,同时还呈现明显空洞影、斑片状影,伴有明显腋窝、纵隔淋巴结肿大及心包、胸腔积液等情况。结论胸部CT检查方式用于艾滋病伴肺结核患者诊断,能够获得明显影像学特征,有助于诊断准确率提高。  相似文献   
6.
Saskatchewan has the highest rate of new human immunodeficiency virus (HIV) infections in Canada. Of those newly diagnosed, 56% identify as female, 76% identify as Indigenous, and 71% report a history of intravenous drug use. These statistics are strikingly different compared with Canadian data. This brief communication describes prenatal care provided to women living with HIV at an interdisciplinary primary care clinic in Saskatchewan, demonstrating that, despite facing great barriers such as housing insecurity, substance use, and institutionalized racism, women living with HIV can have positive outcomes, including engagement in care and the prevention of perinatal HIV infection.  相似文献   
7.
目的 了解青年学生艾滋病主动检测意愿的现状,提出促进青年学生主动检测意愿的建议,为进一步提高青年学生艾滋病检测意愿的策略和措施提供科学依据。方法 采用自编促进大学生HIV主动检测意愿调查问卷,用整群抽样方法抽取成都某高校778名在校大学进行问卷调查。结果 在被调查的778名大学生中,91.6%的学生有艾滋主动检测意愿,在不同年级(χ2=11.416,P=0.010)、认为自己感染艾滋病风险情况(χ2=18.615,P<0.001)等因素上差异均有统计学意义。多因素 logistic 回归分析显示年级为大二或大三、认为自己艾滋病感染风险为非常低或比较低或一般(P均<0.05)的青年学生更愿意进行艾滋病主动检测。结论 该高校大学生艾滋病主动检测意愿较高。应该结合该高校学生的特性,开展有针对性的艾滋病宣传教育活动,以此提高大学生HIV主动检测率。  相似文献   
8.
9.

Purpose

Understanding the attitudes of physicians toward the use of pre-exposure prophylaxis (PrEP) for HIV prevention among youth is critical to improving access to PrEP. We examined PrEP-related attitudes among physicians who provide primary care to 13- to 21-year-old adolescents.

Methods

Individual, in-depth, semistructured interviews were conducted with 38 physicians from adolescent medicine, family practice, internal medicine/medicine-pediatrics, obstetrics/gynecology, and pediatrics who care for any adolescents younger than 18 years. Interviews assessed familiarity with PrEP, perceived benefits and barriers to providing PrEP to adolescents, facilitating factors for prescribing PrEP, and likelihood of recommending and prescribing PrEP to adolescents.

Results

Mean age was 44.6 years (standard deviation 10.9). Fourteen physicians (37%) reported being somewhat or very familiar with PrEP. Perceived benefits of prescribing PrEP included decreased acquisition/rates of HIV, improved provision of sexual health services, and improved patient awareness of HIV risk. Barriers to PrEP were reported at the patient (e.g., lack of acceptability to patients), provider (e.g., concerns about patient adherence, safety/side effects, parents as a barrier to PrEP use), and system (e.g., high cost) levels. Facilitating factors for prescribing PrEP included low cost/coverage by insurance, physician education about PrEP, patient educational materials, and clinical guidelines for PrEP use in youth. A higher proportion of physicians reported being highly or somewhat likely to recommend (N = 16, 42%) than prescribe PrEP (N = 13, 34%).

Conclusions

In this study of primary care physician attitudes toward PrEP prescribing for adolescents, physicians identified numerous barriers to providing PrEP. Addressing these barriers may increase adolescents' access to PrEP.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号